Skip to content

A trial to compare eefect of Aragvadha Kshara and Apamarga Kshara in chronic Wounds

A comparative clinical study to evaluate the efficacy of Aragvadha Kshara and Apamarga Kshara application in Dushta Vrana - NILL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097300
Enrollment
100
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z736- Limitation of activities due to disability Health Condition 2: Z729- Problem related to lifestyle, unspecified

Interventions

None listed

Sponsors

DR NAYAK LEENA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A.Patients with controlled type 2 diabetis melitus B.Subjects suffering from non-healing ulcer / wound - bad smell (Puti Gandha), abnormal colour (Vikruta Varna) with profuse discharge (Srava), severe pain (Vedana), deformity (Vikruti), Hypergranuation (utsanna mamsa), Itchhing(Kandu), Hard(Kathina) and longer healing time C.Size of the Dushta vrana will be of 10cm

Exclusion criteria

Exclusion criteria: A.Patient with Un Controled Diabetes Mellitus, Tubericulosis Malignancy. B.Subjects with disorders like Tuberculosis, Leprosy, HIV, Vascular ulcers, Decubitus ulcers, Malignancy and underlying bony lesions.

Design outcomes

Primary

MeasureTime frame
HEALING OF DUSTHA VRANATimepoint: HEALING OF DUSTHA VRANA CONVERSATION OF DUSTHA VRANA INTO SHUDDHA VRANA WITH IN 4 WEEKS OR 28 DAYS

Secondary

MeasureTime frame
BETTER HEALING OF DUSTHA VRANA AND CONVERSION OF DUSTHA VRANA IN TO SHUDDHA VRANATimepoint: MUCH IMPROVEMENT SEEN WITH IN 6 WEEKS OR 42 DAYS

Countries

India

Contacts

Public ContactDr Nayak Leena

N.K.JABSHETTY AYURVEDIC MEDICAL COLLEGE AND PG CENTRE BIDAR

drchalli42@gmail.com9448222610

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026